257 essays 1,087 funds measured independent · not paid by any fund or issuer we cover

Fund · JPMorgan International Value ETF · measured from SEC filings

JIVE holdings

JIVE reports 375 holdings and behaves like 155.9 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-07-31. The fact sheet publishes the first number; this page computes the second, and traces it across 11 quarters of filings.

Measured concentration

as of 2026-07-31
375 Positions reported
155.9 Effective holdings
2.4× Concentration multiple
17.62% Top ten weight

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 16.82% at a quoted market price (level 1), 42 issuer countries, 2.36% restricted securities.

What stands out

as of 2026-07-31

The largest line in JIVE's filing is not a stock but JPMorgan Prime Money Market Fund, Class IM, a short-term position at 3.27% of net assets. Ten companies are 17.62% of the fund; the other 365 share the rest. Among the 721 equity funds measured here, JIVE behaves like 155.9 holdings against a median of 42.4 — 3.7 times the median. Across 11 quarterly filings JIVE has held roughly steady since 2023-10-31 (152.3 then, 152.9 now). Between the 2026-01-31 and 2026-04-30 filings 57 positions were added and 57 dropped; 20.6% of the weight moved. Japan is the largest country at 12.79% of the portfolio, across 42 countries in the filing.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Every filing since 2023

11

Between 2023-10-31 and 2026-04-30, JIVE went from behaving like 152.3 equally weighted positions to 152.9 — 0% more, while its top ten went from 16.41% to 17.65% of net assets. Read across the funds on the concentration-over-time table.

PeriodHoldingsEffective Top 10Largest
2026-04-30 362 152.9 17.65% 3.27%
2026-01-31 361 186.2 14.97% 2.39%
2025-10-31 355 193.8 14.34% 1.99%
2025-07-31 336 204.3 13.52% 1.88%
2025-04-30 333 178.3 14.85% 2.97%
2025-01-31 335 193.1 14.24% 2.11%
2024-10-31 329 191.8 14.47% 1.88%
2024-07-31 312 189.1 14.31% 1.93%
Earlier filings (3 more, back to 2023-10-31)
PeriodHoldingsEffectiveTop 10Largest
2024-04-30 314 201.9 12.76% 1.97%
2024-01-31 278 184.6 13.6% 1.88%
2023-10-31 228 152.3 16.41% 2.15%

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

Largest positions, as filed

as of 2026-04-30

The 15 largest of 375 positions in JIVE's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: JIVE.csv.gz.

#PositionWeightCumulative
1JPMorgan Prime Money Market Fund3.27%3.3%
2Samsung Electronics Co. Ltd.2.92%6.2%
3HSBC Holdings plc1.76%8.0%
4Roche Holding AG1.62%9.6%
5Nestle SA1.52%11.1%
6Shell plc1.44%12.5%
7Royal Bank of Canada1.43%14.0%
8Taiwan Semiconductor Manufacturing Co. Ltd.1.35%15.3%
9Mitsubishi UFJ Financial Group, Inc.1.17%16.5%
10BHP Group Ltd.1.17%17.7%
11TotalEnergies SE1.11%18.8%
12Toronto-Dominion Bank (The)1.08%19.8%
13Banco Santander SA1.05%20.9%
14Allianz SE1.04%21.9%
15Rio Tinto plc0.92%22.9%

By country of issuer

as of 2026-04-30

Share of JIVE's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

CountryShare
Japan 13.97%
United Kingdom 10.17%
Canada 7.45%
South Korea 6.63%
China 5.92%
France 5.32%
Taiwan 4.30%
Switzerland 4.27%

Returns the fund reported

2023-08 – 2026-04

Monthly total returns from Item B.5 of JIVE's own filings, 33 months on record. Not computed here and not from a price feed.

47.2%Last twelve months filed
100%Whole series, compounded
7.8%Best month
-7.4%Worst month

Cross-checked against a series computed separately from prices: median difference — percentage points over 0 months, which is roughly the distributions. Every month with the filing it came from: JIVE.json · all funds.

Who borrows JIVE's shares

2026-07-31

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $18m was out to 4 borrowers. The largest, BofA Securities, Inc., held 88.8% of it.

BorrowerOn loanShare of the loan
BofA Securities, Inc. $16m 88.8%
MORGAN STANLEY & CO LLC $1m 6.6%
CITIGROUP GLOBAL MARKETS INC. $717,569 4.0%
HSBC BANK PLC $107,402 0.6%

The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter JIVE has filed, with each borrower: JIVE.json · all funds.

Since the previous filing

2026-01-31 → 2026-04-30

357 positions became 357: 57 added (12.6% of the fund at the later date), 57 dropped (12.7% at the earlier date). Half the sum of all weight changes, a turnover proxy: 20.6%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of JIVE compared this way, as a feed: changes.xml · all funds: filings received.

Largest increases2026-01-312026-04-30Largest decreases2026-01-312026-04-30
JPMorgan Prime Money Market Fund1.17%3.27% Banco Bilbao Vizcaya Argentaria SA0.97%0.76%
Royal Bank of Canada0.31%1.43% Lloyds Banking Group plc0.47%0.27%
Samsung Electronics Co. Ltd.2.39%2.92% Toyota Motor Corp.0.68%0.52%
China Construction Bank Corp.0.39%0.70% Capgemini SE0.25%0.10%
Industrial & Commercial Bank of China Ltd.0.24%0.51% China Life Insurance Co. Ltd.0.37%0.23%
TotalEnergies SE0.90%1.11% China Hongqiao Group Ltd.0.37%0.23%

New: Roche Holding AG (1.62%), Toronto-Dominion Bank (The) (1.08%), Hon Hai Precision Industry Co. Ltd. (0.61%), Glencore plc (0.41%), Koninklijke Ahold Delhaize NV (0.40%), Equinor ASA (0.34%). Gone: Roche Holding AG (2.02%), British American Tobacco plc (0.82%), SSE plc (0.36%), Toyota Tsusho Corp. (0.35%), Cie Generale des Etablissements Michelin SCA (0.34%), Orange SA (0.32%).

Asset categories and pricing

as of 2026-07-31

97.20% equity, 2.80% short-term investment as filed; 16.8% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.

Derivative exposure and counterparties

as of 2026-04-30

A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $2.29B. Notional of an interest-rate or currency swap is not equity exposure.

96.82%Stocks held directly
0%Swap notional (0)
0.66%Futures notional (2)
97.5%Sum, % of net assets

Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).

Neighbours by effective holdings, equity funds

10

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of JIVE (155.9). Same filings, same arithmetic. Position in this list says nothing about which fund is better.

FundReportsBehaves likeTop tenAs of
SPGM State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF 2,945 143.9 20.69% 2026-06-30
MDYG State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF 245 144.6 14.43% 2026-06-30
AVMV Avantis U.S. Mid Cap Value ETF 305 148.8 13.49% 2026-05-31
FNDF Schwab Fundamental International Equity ETF 891 149.8 17.1% 2026-05-31
IPAC iShares Core MSCI Pacific ETF 1,380 149.9 18.4% 2026-07-31
FTC First Trust Large Cap Growth AlphaDEX Fund 188 156.2 9.73% 2026-07-31
FEP First Trust Europe AlphaDEX Fund 202 160.4 10.24% 2026-06-30
DFIV Dimensional International Value ETF 634 161.3 15.59% 2026-07-31
DIVI Franklin International Core Dividend Tilt Index ETF 416 167.7 14.31% 2026-06-30
IMCG iShares Morningstar Mid-Cap Growth ETF 261 168.8 12% 2026-07-31

Essays that examine JIVE

0

Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.